Rezurock (belumosudil)
pCPA File Number:
22595
Negotiation Status:
Active Negotiation
Indication(s):
Chronic graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older, after failure of at least two prior lines of systemic therapy.
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
SR0789-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable